Strode Quoted in Behavioral Health Business About Expansion of Autism Services in 2021
17 December 2020
Partner Roger Strode was quoted in the Behavioral Health Business article, “2021 Autism Outlook: Stakeholders Predict Consolidation, Service Expansions in Year Ahead,” which provided insights from executives and insiders in the behavioral health space on predictions for the autism treatment space in 2021.
Strode told Behavioral Health Business, “I think that the end of the pandemic is going to be a major key for autism services.”
“Like all health care providers, these providers have been hit hard by the shutdowns, requirements for social distancing, etc. With vaccines on the way, there is great hope for the health care industry, including autism providers,” Strode said.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”